Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Adherex Technologies Inc. (FENC) vs Orchestra BioMed Holdings, Inc. (OBIO)

Adherex Technologies Inc. and Orchestra BioMed Holdings, Inc. are both Biotechnology companies. Adherex Technologies Inc. and Orchestra BioMed Holdings, Inc. are of similar size ($372.4M and $366.0M). Orchestra BioMed Holdings, Inc. grew revenue faster over the last twelve months: 986.1% against 77.8%. Adherex Technologies Inc. has the higher net margin (−5.49% vs −186.3%) and the lower return on invested capital (−58.9% vs 0.00%). Across the 17 metrics below, Adherex Technologies Inc. leads on 11 and Orchestra BioMed Holdings, Inc. on 6.

Valuation

Metric FENC OBIO Biotechnology median
P/E n/m n/m 7.88
P/S 6.19 11.87 11.47
P/B 8.64 19.65 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 5.80 9.52 10.73
Earnings yield (1.17%) (14.29%) (28.84%)
Free cash flow yield (0.56%) (15.57%) (23.03%)

Profitability

Metric FENC OBIO Biotechnology median
Gross margin 93.73% 99.51% 65.16%
Operating margin (1.90%) (181.36%) 0.00%
Net margin (5.49%) (186.30%) 0.00%
Free cash flow margin (3.44%) (184.83%) 0.00%
Return on equity (18.58%) (607.32%) (57.72%)
Return on assets (5.39%) (75.16%) (49.22%)
Return on invested capital (58.89%) 0.00% 0.00%

Growth

Metric FENC OBIO Biotechnology median
Revenue growth (TTM) 77.83% 986.14% 5.64%
EPS growth (last fiscal year) (2,087.50%) 33.13% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FENC OBIO Biotechnology median
Debt to equity 0.00 1.80 0.00
Current ratio 5.85 8.26 4.73
Net debt to EBITDA 6.02 1.80 0.96

Dividend

Metric FENC OBIO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric FENC OBIO Biotechnology median
Market cap 372.41m 366.04m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack